Lixte Biotechnology Warrants
LIXTW
LIXTW was delisted on the 26th of November, 2025.
3 hedge funds and large institutions have $3.98K invested in Lixte Biotechnology Warrants in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
2.34% less ownership
Funds ownership: 6.19% → 3.85% (-2.3%)
40% less funds holding
Funds holding: 5 → 3 (-2)
55% less capital invested
Capital invested by funds: $8.88K → $3.98K (-$4.9K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EFG
Ethos Financial Group
King Of Prussia,
Pennsylvania
|
-$3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$245 |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$189 |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$93 |
| 5 |
CS
Clear Street
New York
|
-$29 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
1
Warberg Asset Management
Winnetka,
Illinois
| $1.6K | -$93 | -1,968 | -5% |
|
|
2
Citadel Advisors
Miami,
Florida
| $1.46K | -$189 | -3,981 | -12% |
|
|
CS
3
Clear Street
New York
| $922 | -$29 | -600 | -3% |
|
|
EFG
4
Ethos Financial Group
King Of Prussia,
Pennsylvania
| – | -$3K | -42,105 | Closed |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$245 | -4,088 | Closed |
|
LIXTW Hedge Fund Activity: Q3 2024 in Review
3 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Lixte Biotechnology Warrants (LIXTW) for Q3 2024, worth a combined $3.98K — down 55% from $8.88K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of LIXTW and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 0 added.
The largest seller was Ethos Financial Group, exiting entirely with an estimated $3K sold.
- 3 institutional investors held Lixte Biotechnology Warrants (LIXTW) as of Q3 2024, down from 5 in Q2 2024.
- Funds reported $3.98K of Lixte Biotechnology Warrants stock for Q3 2024, down 55% quarter-over-quarter.
- 0 funds opened new Lixte Biotechnology Warrants positions in Q3 2024 and 2 closed out, a net change of -2 holders.
- The largest Lixte Biotechnology Warrants seller in Q3 2024 was Ethos Financial Group, an estimated $3K sold.
Based on aggregated 13F filings for Q3 2024.